Melissa A. Brown
Brisbane, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: application to BRCA1 and BRCA2.
Journal: Human mutation
Published: January 01, 2023
Caution: Plasmid DNA topology affects luciferase assay reproducibility and outcomes.
Journal: BioTechniques
Published: August 02, 2019
MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer.
Journal: British journal of cancer
Published: May 24, 2018
MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancer.
Journal: Oncotarget
Published: May 13, 2018
BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding.
Journal: Human mutation
Published: April 16, 2018
Long Noncoding RNAs CUPID1 and CUPID2 Mediate Breast Cancer Risk at 11q13 by Modulating the Response to DNA Damage.
Journal: American journal of human genetics
Published: February 08, 2017
Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer.
Journal: Human molecular genetics
Published: March 08, 2016
The voltage gated Ca(2+)-channel Cav3.2 and therapeutic responses in breast cancer.
Journal: Cancer cell international
Published: February 04, 2016
The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin.
Journal: Scientific reports
Published: December 18, 2015
Last Updated: 09/26/2026